EPA:BIM - Euronext Paris - Matif - FR0013280286 - Common Stock - Currency: EUR
EPA:BIM (5/2/2025, 7:00:00 PM)
118.6
-0.1 (-0.08%)
The current stock price of BIM.PA is 118.6 EUR. In the past month the price increased by 2.68%. In the past year, price increased by 20.16%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABL.DE | ABBOTT LABORATORIES | 27.53 | 201.04B | ||
IUI1.DE | INTUITIVE SURGICAL INC | 68.78 | 166.16B | ||
BSX.DE | BOSTON SCIENTIFIC CORP | 38.66 | 136.07B | ||
2M6.DE | MEDTRONIC PLC | 15.76 | 95.22B | ||
SHL.DE | SIEMENS HEALTHINEERS AG | 21.34 | 54.16B | ||
BOX.DE | BECTON DICKINSON AND CO | 11.84 | 42.21B | ||
EWL.DE | EDWARDS LIFESCIENCES CORP | 29.17 | 39.27B | ||
DC4.DE | DEXCOM INC | 49.09 | 27.91B | ||
PHIA.AS | KONINKLIJKE PHILIPS NV | 16.35 | 21.36B | ||
PHI1.DE | KONINKLIJKE PHILIPS NV | 16.34 | 21.35B | ||
1PHIA.MI | KONINKLIJKE PHILIPS NV | 16.09 | 21.02B | ||
DIA.MI | DIASORIN SPA | 28.7 | 5.54B |
bioMérieux SA engages in the provision of in vitro diagnostic solutions, which determine the source of disease and contamination. The company is headquartered in Craponne, Auvergne-Rhone-Alpes and currently employs 14,754 full-time employees. The company went IPO on 2004-06-07. The firm designs, develops, manufactures and sells systems used in clinical applications, such as for the diagnosis of tuberculosis, respiratory infections, among others and industrial applications, such as for the analysis of industrial or environmental samples. The firm also provides its customers with related services for the installation and maintenance of instruments, and training for product users. BioMerieux SA operates through its numerous subsidiaries in various countires, including bioMerieux Deutschland GmbH, bioMerieux Austria GmbH, Advencis, bioMerieux Benelux SA/NV, as well as BioFire Diagnostics Inc., chromID CARBA SMART and new bi-plate Petri dish.
BIOMERIEUX
376, chemin de l'Orme
Craponne AUVERGNE-RHONE-ALPES FR
Employees: 14451
Phone: 33478872000
The current stock price of BIM.PA is 118.6 EUR. The price decreased by -0.08% in the last trading session.
The exchange symbol of BIOMERIEUX is BIM and it is listed on the Euronext Paris - Matif exchange.
BIM.PA stock is listed on the Euronext Paris - Matif exchange.
18 analysts have analysed BIM.PA and the average price target is 128.81 EUR. This implies a price increase of 8.61% is expected in the next year compared to the current price of 118.6. Check the BIOMERIEUX stock analysts ratings, price target forecast and up-and down grades for more detailed information.
BIOMERIEUX (BIM.PA) has a market capitalization of 14.04B EUR. This makes BIM.PA a Large Cap stock.
BIOMERIEUX (BIM.PA) currently has 14451 employees.
BIOMERIEUX (BIM.PA) has a support level at 117.6 and a resistance level at 118.61. Check the full technical report for a detailed analysis of BIM.PA support and resistance levels.
The Revenue of BIOMERIEUX (BIM.PA) is expected to grow by 7.97% in the next year. Check the estimates tab for more information on the BIM.PA EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
BIOMERIEUX (BIM.PA) has a dividend yield of 0.76%. The yearly dividend amount is currently 0.85. Check the full fundamental report for a detailed analysis of BIM.PA dividend history, reliability and sustainability.
BIOMERIEUX (BIM.PA) will report earnings on 2025-05-15.
The PE ratio for BIOMERIEUX (BIM.PA) is 30.73. This is based on the reported non-GAAP earnings per share of 3.86 and the current share price of 118.6 EUR. Check the full fundamental report for a full analysis of the valuation metrics for BIM.PA.
ChartMill assigns a technical rating of 9 / 10 to BIM.PA. When comparing the yearly performance of all stocks, BIM.PA is one of the better performing stocks in the market, outperforming 84.57% of all stocks.
ChartMill assigns a fundamental rating of 6 / 10 to BIM.PA. Both the health and profitability get an excellent rating, making BIM.PA a very profitable company, without any liquidiy or solvency issues.
Over the last trailing twelve months BIM.PA reported a non-GAAP Earnings per Share(EPS) of 3.86. The EPS increased by 21.01% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 10.86% | ||
ROA | 7.49% | ||
ROE | 10.28% | ||
Debt/Equity | 0.08 |
ChartMill assigns a Buy % Consensus number of 77% to BIM.PA. The Buy consensus is the average rating of analysts ratings from 18 analysts.
For the next year, analysts expect an EPS growth of 20.14% and a revenue growth 7.97% for BIM.PA